Back to Search
Start Over
Earlier use of androgen receptor-axis-targeted drugs may improve overall survival in patients with non-metastatic castration-resistant prostate cancer.
- Source :
- Prostate; Jul2018, Vol. 78 Issue 10, p766-772, 7p
- Publication Year :
- 2018
Details
- Language :
- English
- ISSN :
- 02704137
- Volume :
- 78
- Issue :
- 10
- Database :
- Complementary Index
- Journal :
- Prostate
- Publication Type :
- Academic Journal
- Accession number :
- 129858977
- Full Text :
- https://doi.org/10.1002/pros.23534